Your browser doesn't support javascript.
loading
Cost-benefit impact of free asthma medication provision for the pediatric population.
Koltermann, Vanessa; Friedrich, Frederico Orlando; Fensterseifer, Ana Carolina; Ongaratto, Renata; Pinto, Leonardo Araújo.
Afiliação
  • Koltermann V; Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil. Electronic address: vanessa.koltermann@gmail.com.
  • Friedrich FO; Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil. Electronic address: fredericofriedrich@gmail.com.
  • Fensterseifer AC; Medical School, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 90610-000, Porto Alegre, RS, Brazil. Electronic address: anacarolinafens@gmail.com.
  • Ongaratto R; Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil. Electronic address: re_ongaratto@hotmail.com.
  • Pinto LA; Department of Pediatrics, Infant Center, Pontificia Universidade Católica do Rio Grande do Sul, Ipiranga Avenue 6690, Building 60, 2 nd floor, 90610-000, Porto Alegre, RS, Brazil. Electronic address: leonardo.pinto@pucrs.br.
Respir Med ; 164: 105915, 2020 04.
Article em En | MEDLINE | ID: mdl-32217290
BACKGROUND: Asthma is a common chronic disease in childhood, resulting in high costs for health care systems and society. As of June 2011, the Brazilian Unified Health System (SUS) provides free asthma medications for the population. This study evaluated the impact of this program on asthma admissions in the population aged 1-19 years. In addition, a cost-benefit analysis compared data before and after the introduction of the program. METHODS: This descriptive study was based on information from SUS Information Technology Department (DATASUS). Admission rates and costs of patients aged 1-19 years with diagnosed asthma were compared before (2008-2010) and after (2012-2017) the provision of free inhaled corticosteroid. RESULTS: The asthma admission rate reduced by 28.4% when comparing the two periods (OR 0.71; 95% CI 0.64-0.79). Children aged 1-4 years had a 27.3% reduction in asthma admissions (OR 0.72; 95% CI 0.63-0.82), while those aged 15-19 years had a 39.65% decrease (OR 0.59; 95% CI 0.37-0.95). Asthma admission costs decreased when comparing the two periods (OR 0.68; 95% CI 0.62-0.74). After the introduction of the program, mean cost savings reached US $27,865,905.08 in children aged 1-4 years and US $21,350,660.63 in those aged 5-19 years. CONCLUSION: The economic burden of pediatric asthma on Brazil's public health care system is significant. From 2012 to 2015, free provision of inhaled corticosteroid was cost-effective in all age groups. In 2017, no cost-benefit effect was observed in this population, but asthma admission rate decreased.
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Asma / Análise Custo-Benefício / Corticosteroides / Antiasmáticos / Atenção à Saúde / Programas Governamentais Tipo de estudo: Health_economic_evaluation Aspecto: Determinantes_sociais_saude Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Respir Med Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Admissão do Paciente / Asma / Análise Custo-Benefício / Corticosteroides / Antiasmáticos / Atenção à Saúde / Programas Governamentais Tipo de estudo: Health_economic_evaluation Aspecto: Determinantes_sociais_saude Limite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Região como assunto: America do sul / Brasil Idioma: En Revista: Respir Med Ano de publicação: 2020 Tipo de documento: Article País de publicação: Reino Unido